(Total Views: 509)
Posted On: 10/05/2024 5:48:30 PM
Post# of 148863
Hi OHM, could you please speak to the length of the CRC trial ? It's not clear to me. Thank you.
"TAS-102 and bevacizumab will be administered for three of four weeks in a four-week cycle, and leronlimab (at doses of 350 mg or 700 mg) will be administered weekly. The study will include a safety lead-in treating five patients in the 350 mg leronlimab arm prior to beginning enrollment to the 700 mg leronlimab arm."
"TAS-102 and bevacizumab will be administered for three of four weeks in a four-week cycle, and leronlimab (at doses of 350 mg or 700 mg) will be administered weekly. The study will include a safety lead-in treating five patients in the 350 mg leronlimab arm prior to beginning enrollment to the 700 mg leronlimab arm."
(1)
(0)Scroll down for more posts ▼
